What does the BAT webinar say about treatment
Bipolar Androgen Therapy (BAT) Webinar - Treatment Information
I found multiple webinars about BAT in our educational resources. Here's what they cover:
🎓 COMMUNITY LEARNING & EMERGING INSIGHTS (Tier 3 - Educational)
⚠️ NOTE: This content is from educational webinars and community discussions. These represent expert perspectives and patient experiences that have not yet been incorporated into official clinical guidelines.
Primary BAT Webinars Available:
Webinar #56: "Bipolar Androgen Therapy for Prostate Cancer"
Speaker: Dr. [removed] Antonarakis
Watch/Download: https://felofmlhqwcdpiyjgstx.supabase.co/storage/v1/object/public/guideline-pdfs/webinars/Bipolar-Androgen-Therapy-for-Prostate-Cancer-Emmanuel-Antonarakis-56.pdf
Key Treatment Concepts Covered:
- How BAT works: Alternating between androgen deprivation therapy (removing testosterone) and high-dose testosterone flooding
- PSA response patterns: The webinar emphasizes that PSA may initially rise before falling—this is normal and doesn't mean treatment is failing
- When BAT is appropriate: BAT is NOT recommended for hormone-sensitive prostate cancer in early disease stages (it can stimulate cancer growth). It's intended for castration-resistant prostate cancer
- Response rates and duration: Dr. [removed] discusses 8 different BAT studies treating 402 patients over a decade, with varying response durations
- Biomarker considerations: Higher AR (androgen receptor) activity generally predicts better BAT response; AR-V7 splice variants may predict poor response
Webinar #21: "Bipolar Androgen Therapy" - Patient Experience & Evolutionary Strategy
Speakers: Bryce Olson (patient) and Dr. [removed] Gatenby (adaptive therapy expert)
Watch/Download: https://felofmlhqwcdpiyjgstx.supabase.co/storage/v1/object/public/guideline-pdfs/webinars/Bipolar-Androgen-Therapy-Bryce-Olson-and-Bob-Gatenby-21.pdf
Key Treatment Concepts Covered:
- Real-world example: A patient with advanced prostate cancer who had received 12 prior treatment lines saw his PSA drop from 307 to 5 within 6 weeks of BAT
- Evolutionary strategy: Using BAT to exploit cancer cell vulnerabilities by cycling between testosterone deprivation and flooding
- Combination potential: Discussion of how BAT might be followed by other therapies (like chemotherapy or immunotherapy) to prevent resistance
- Important caution: Even with dramatic PSA drops, resistance may eventually develop—ongoing monitoring and adaptive strategy adjustments are needed
Webinar #10: "Adaptive Therapy"
Speaker: Brad Power
Watch/Download: https://www.leafscience.org/webinar-10/
BAT-Related Content:
- Discusses BAT as an example of evolutionary/adaptive therapy principles
- Explains how BAT differs from standard continuous treatment approaches
- Covers the theory behind why alternating treatments may prevent resistance development
Important Clinical Boundaries:
⚠️ These webinars are educational discussions, not clinical recommendations. They represent:
- Expert opinions from experienced researchers
- Patient experiences and case studies
- Emerging research approaches
Your oncologist will determine:
- Whether BAT is appropriate for YOUR specific cancer stage and characteristics
- The right timing for BAT in your treatment sequence
- How to monitor your response
- What biomarkers or tests might predict your likelihood of responding
Questions to Ask Your Oncology Team:
- Is my prostate cancer castration-resistant or hormone-sensitive? (This determines BAT eligibility)
- Have you considered BAT as an option for my specific situation?
- What biomarkers or genetic tests might predict whether I'd respond to BAT?
- If PSA rises initially during BAT, how will you distinguish between normal response patterns and treatment failure?
- What monitoring schedule would you use if I pursued BAT?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated November 30, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Prostate Cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Prostate Cancer
- Why does chinese medicine say fresh mozzarelly, ricotta, cottage cheese are ok, but not hard cheeses
- What to know before getting adp treatment
- What are the treatment options for prostate cancer
- What can I do if my insurance denies my prostate cancer treatment
- What happens if I choose no treatment for Prostate Cancer
- What is the risk of getting a second cancer after Prostate Cancer treatment
- What can I do if I cannot afford Prostate Cancer treatment
- What type of follow-up will I need after Prostate Cancer treatment